Glucotrack GCTK
NASDAQ GCTK
$0.35 +0.01 (+1.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Glucotrack (GCTK) Amortization of Deferred Charges (2024 - 2025)

Glucotrack's (GCTK) quarterly Amortization of Deferred Charges came in at $177000.0 in Q4 2025, down 40.6% YoY from $298000.0 in Q4 2024, and up 470.97% on a QoQ basis from $31000.0 in Q3 2025.

Glucotrack (GCTK) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Glucotrack (GCTK) has 2 years of Amortization of Deferred Charges data on file, last reported at $177000.0 in Q4 2025.

  • Quarterly Amortization of Deferred Charges fell 40.6% year-over-year to $177000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (down 66.08% YoY) and the FY2025 annual result came in at $182000.0, down 71.02% from the prior year.
  • Amortization of Deferred Charges advanced to $177000.0 in Q4 2025, from $31000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $298000.0 in Q4 2024 to a low of $2000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Glucotrack 1.68 Mn 553,542.53 -

Historic Data

Download Data
DateValue
Dec 31, 2025 177,000.00
Dec 31, 2025 177,000.00
Sep 30, 2025 31,000.00
Sep 30, 2025 31,000.00
Jun 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 3,000.00
Mar 31, 2025 3,000.00
Dec 31, 2024 298,000.00
Dec 31, 2024 298,000.00
Sep 30, 2024 251,000.00
Sep 30, 2024 251,000.00
Mar 31, 2024 79,000.00
Mar 31, 2024 79,000.00